About 5,370,000 results
GSK announces positive results from DREAMM-8 phase III trial for ...
After withdrawal, GSK touts another Blenrep combo win as …
FDA approves GSK’s BLENREP (belantamab mafodotin-blmf) for …
DREAMM-7 phase III trial shows Blenrep combination nearly tripled ... - GSK
GSK details Blenrep combo data that could bring the multiple …
DREAMM-8 Phase III Trial for Blenrep | Int'l Myeloma Foundation
New data presented at ASH 2021 highlight potential of Blenrep
Phase III Blenrep Trial | Int'l Myeloma Foundation
FDA approves GSK's Blenrep for advanced multiple myeloma
GSK's blood cancer drug meets primary goal in late-stage trial